Vanguard Capital Management’s iSpecimen ISPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-31
Closed -$82 – 4103
2026
Q2
$82 Hold
31
– – ﹤0.01% 4090
2026
Q1
$194 Hold
31
– – ﹤0.01% 4059

Other funds holding ISPC

Vanguard Capital Management's ISPC Position: Q3 2026 in Review

Vanguard Capital Management sold out of iSpecimen (ISPC) in Q3 2026, closing a stake of 31 shares — an estimated $82 sold.

Vanguard Capital Management first reported a position in ISPC in Q1 2026 and held it in 2 quarters. The position peaked at $194 in Q1 2026. 9 funds tracked by Wall St. Rank hold ISPC as of Q3 2026.

  • Vanguard Capital Management reported no remaining iSpecimen position as of Q3 2026 after selling out during the quarter.
  • Vanguard Capital Management sold 31 iSpecimen shares in Q3 2026, an estimated $82.
  • Vanguard Capital Management first reported a position in iSpecimen in Q1 2026 and held it in 2 quarters.
  • Vanguard Capital Management's iSpecimen position peaked at $194 in Q1 2026.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.